This Coverage with Evidence Development (CED) study evaluates the long-term health outcomes of patients with symptomatic, severe or greater Tricuspid Regurgitation who received a Tricuspid Transcatheter Edge-to-Edge Repair (T-TEER) procedure using the TriClip system.
The TRICARE will assess 2-year effectiveness in patients with symptomatic, severe or greater TR who undergo Tricuspid Transcatheter Edge-to-Edge Repair (T-TEER) with the TriClip system, as compared to a contemporaneous control of patients without T-TEER.
Study Type
OBSERVATIONAL
Enrollment
2,200
The TriClip System
Abbott
Santa Clara, California, United States
RECRUITINGComposite of heart failure hospitalization or all-cause mortality
Compare the rate of composite endpoint at 2 years between the treatment and control groups.
Time frame: 2 years
Tricuspid valve re-intervention
Report the rate at 2 years for the treatment group
Time frame: 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.